Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: J Am Acad Child Adolesc Psychiatry. 2020 Aug 1;60(4):458–469. doi: 10.1016/j.jaac.2020.07.892

Table 1.

Demographic and Clinical Variables for High-Risk and Healthy Comparison Youth

Group Analysis Healthy Comparison (HC) (N=30) High Risk (HR) (N=34) Statistics

Site (Stanford/UCLA) 21/9 17/17 χ2(1)=2.64; p=.10

Age (SD) 14.41 (2.27) 13.98 (2.64) t(62)=.70; p=.48

Sex (F/M) 16/14 19/15 χ2(1)=0.04; p=.84

Motion: absolute mean displacement (mm) (mean, SD, range) .22 (.34), [.04–1.95] .33 (.29), [.07–1.17] t(62)=1.37; p=.18

Treatment Group Analysis HR FFT-HR (n=16) HR EC (n=18) Statistics

pre post pre post Pre post

Site (Stanford/UCLA) 7/9 -- 10/8 -- χ2(1)=0.47; p=.49 --

Age (SD) 14.57 (2.39) 15.02 (2.37) 13.45 (2.80) 13.84 (2.79) t(32)=1.24; p=.22 t(32)=1.30; p=.20

Sex (F/M) 8/8 -- 7/11 -- χ2(1)=0.42; p=.52 --

Motion: absolute mean displacement (mm) (mean, SD, range) .31 (.25), [.07–.77] .36 (.29), [.10–1.22] .35 (.33), [.08–1.17] .30 (.33), [.07–1.17] t(32)=−.33; p=.74 t(32)=.50 p=.62

CDRS-R mean (SD) 46.87 (10.31) 39.56 (13.07) 50.67 (17.67) 36.83 (15.99) t(32)=−.75; p=.46 t(32)=.54; p=.59

YMRS mean (SD) 10.00 (7.73) 8.25 (6.12) 11.78 (6.23) 9.28 (5.54) t(32)=−.74; p=.46 t(32)=−.51; p=.61

Primary Diagnosis
 MDD 11 (69%) 9 (50%) χ2(1)=1.23;
 BD-NOS 5 (31%) 9 (50%) p=.27

Medications at Baseline
 Unmedicated 4 (25%) 10 (55%) χ2(1)=3.26; p=.07
 Antidepressant 8 (50%) 2 (11%) χ2(1)=6.17; p=.01
 Antipsychotic 3 (19%) 7 (39%) χ2(1)=2.06; p=.36
 Anticonvulsant 4 (25%) 2 (11%) χ2(1)=1.12; p=.29
 Anxiolytic 0 (0%) 1 (6%) χ2(1)=.92; p=.34
 Stimulant 4 (25%) 4 (22%) χ2(1)=.04; p=.85

Note: BD-NOS =Bipolar Disorder, Not Otherwise Specified; CDRS-R = Children’s Depression Rating Scale-Revised; EC = Enhanced Care; FFT-HR = Family Focused Therapy for High-Risk Youth; MDD = Major Depressive Disorder; YMRS = Youth Mania Rating Scale; values indicate mean ± SD = standard deviation.